Innovations and Emerging Therapies to Combat Renal Cell Damage: NAD + As a Drug Target
- 15 November 2021
- journal article
- review article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 35 (17) , 1449-1466
Abstract
Significance: Acute kidney injury (AKI) is a common and life-threatening complication in hospitalized and critically ill patients. It is defined by an abrupt deterioration in renal function, clinically manifested by increased serum creatinine levels, decreased urine output, or both. To execute all its functions, namely excretion of waste products, fluid/electrolyte balance, and hormone synthesis, the kidney requires incredible amounts of energy in the form of adenosine triphosphate. Recent Advances: Adequate mitochondrial functioning and nicotinamide adenine dinucleotide (NAD + ) homeostasis are essential to meet these high energetic demands. NAD + is a ubiquitous essential coenzyme to many cellular functions. NAD + as an electron acceptor mediates metabolic pathways such as oxidative phosphorylation (OXPHOS) and glycolysis, serves as a cosubstrate of aging molecules ( i.e. , sirtuins), participates in DNA repair mechanisms, and mediates mitochondrial biogenesis. Critical Issues: In many forms of AKI and chronic kidney disease, renal function deterioration has been associated with mitochondrial dysfunction and NAD + depletion. Based on this, therapies aiming to restore mitochondrial function and increase NAD + availability have gained special attention in the last two decades. Future Directions: Experimental and clinical studies have shown that by restoring mitochondrial homeostasis and increasing renal tubulo-epithelial cells, NAD + availability, AKI incidence, and chronic long-term complications are significantly decreased. This review covers some general epidemiological and pathophysiological concepts; describes the role of mitochondrial homeostasis and NAD + metabolism; and analyzes the underlying rationale and role of NAD + aiming therapies as promising preventive and therapeutic strategies for AKI. Antioxid. Redox Signal . 35, 1449–1466.Keywords
This publication has 138 references indexed in Scilit:
- The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced ObesityCell Metabolism, 2012
- Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injuryKidney International, 2012
- Development of Oxidative Stress in the Peritubular Capillary Microenvironment Mediates Sepsis-Induced Renal Microcirculatory Failure and Acute Kidney InjuryThe American Journal of Pathology, 2012
- Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?Pharmacological Reviews, 2012
- Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injuryFree Radical Biology and Medicine, 2011
- Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survivalKidney International, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- A Mitochondrial Protein Compendium Elucidates Complex I Disease BiologyCell, 2008
- Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-γ coactivator 1αProceedings of the National Academy of Sciences, 2006
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003